First results of a phase II study (STIMULUS-AML1) investigating sabatolimab plus azacitidine plus venetoclax in patients with newly diagnosed acute myeloid leukemia (ND AML) Meeting Abstract
| Authors: | Zeidan, A. M.; Westermann, J.; Kovacsovics, T.; Assouline, S.; Schuh, A. C.; Kim, H. J.; Macias, G. R.; Sanford, D.; Luskin, M. R.; Stein, E. M.; Malek, K.; Lyu, J. Y.; Stegert, M.; Esteve, J. |
| Abstract Title: | First results of a phase II study (STIMULUS-AML1) investigating sabatolimab plus azacitidine plus venetoclax in patients with newly diagnosed acute myeloid leukemia (ND AML) |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | clinical trial; phase ii; azacitidine; aml; acute myeloid leukemia; venetoclax; sabatolimab |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S255 |
| Language: | English |
| ACCESSION: | WOS:000897948100182 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01303-9 |
| Notes: | Meeting Abstract: AML-484 -- Source: Wos |
